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Background: Chloroperoxidase (CPO) is a versatile heme-
containing enzyme that exhibits peroxidase, catalase and
cytochrome P450-like activities in addition to catalyzing
halogenation reactions. The structure determination of CPO
was undertaken to help elucidate those structural features
that enable the enzyme to exhibit these multiple activities.
Results: Despite functional similarities with other heme
enzymes, CPO folds into a novel tertiary structure domi-
nated by eight helical segments. The catalytic base,
required to cleave the peroxide 0-0 bond, is glutamic
acid rather than histidine as in other peroxidases. CPO
contains a hydrophobic patch above the heme that could
be the binding site for substrates that undergo P450-like
reactions. The crystal structure also shows extensive glyco-
sylation with both N- and O-linked glycosyl chains.
Conclusions: The proximal side of the heme in CPO
resembles cytochrome P450 because a cysteine residue
serves as an axial heme ligand, whereas the distal side of the
heme is 'peroxidase-like' in that polar residues form the
peroxide-binding site. Access to the heme pocket
is restricted to the distal face such that small organic
substrates can interact with an iron-linked oxygen atom
which accounts for the P450-like reactions catalyzed by
chloroperoxidase.
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Introduction
Halogenation of aliphatic molecules gives rise to a wide
variety of natural products, some of which, like chloram-
phenicol, are of medicinal value [1]. Enzyme-catalyzed
halogenation reactions most often involve oxidation of
the halide ion and formation of a C-X bond. The heme
enzyme, chloroperoxidase (CPO), from the fungus Cal-
dariomyces fiimago, participates in the production of the
natural product caldariomycin (1,1 -dichloro-2,5-dihy-
droxy cyclopentane) [2]. The overall catalytic cycle of
CPO is characteristic of many heme peroxidases (Fig. la).
Although the primary biological function of CPO is
chlorination [2], CPO also catalyzes other oxidative reac-
tions characteristic of other heme peroxidases, catalase
and cytochrome P450 (Fig. lb) [3]. Owing to this diver-
sity, CPO is the most versatile of the known heme
enzymes and has been the subject of extensive investiga-
tions since the enzyme was first described by Morris and
Hager in 1966 [2]. One of the main conclusions from
these studies is that CPO appears to share properties with
both P450s and heme peroxidases. CPO and P450s share
various spectroscopic properties [4,5] which indicate
that, like P450, one of the axial heme ligands in CPO
derives from the sulfur atom of a cysteine residue. In
contrast, heme peroxidases use histidine as a ligand.
However, the distal heme pocket in CPO, which forms
the peroxide-binding site, is predicted to be formed
primarily by polar amino acids [6-8]. This is in sharp
contrast with P450s in which the distal oxygen-binding
site is lined primarily with non-polar groups. Hence,
CPO is thought to have a P450-like proximal pocket and
a peroxidase-like distal pocket.
Another important property of both peroxidases and
P450s is accessibility to the heme group. In peroxidases,
substrates are limited to electron-transfer reactions at the
heme edge with restricted or no direct access to the
Fe4+=O center in compound I [9]. In sharp contrast, the
P450 heme edge is not accessible and substrates must
bind directly adjacent to the Fe4 +=O center for stereo-
specific hydroxylation [10]. CPO can do both, but
whether this is due to multiple access routes to the heme
remains unknown. The structure of this rather unusual
and functionally diverse heme enzyme should help us
(a) Fe3+P+H 2 02 - Fe4 +=O P +H20
Compound I
Fe4+=O P' + substrate -- Fe4+=O P + substrate'
Compound II




RH+ H202 +CI-+ H
+
- R-CI + 2H 20
2RH + H202 -- R-R + 2H 20
H202 decomposition 2H 202 -02+2H 20(catalase)
Oxygen insertion
(P450)
R+ H2 02 - R-O+ H20
Fig. 1. (a) Overall catalytic cycle of heme peroxidases. In the first
step, hydrogen peroxide removes one electron from the iron
atom and one from the porphyrin (P) to give the oxyferryl
(Fe4+=O) center and a porphyrin rr cation radical [33]. In the sec-
ond step, compound I is reduced by a substrate molecule, and in
the third and last step of the cycle, a second molecule of sub-
strate is oxidized. (b) Reactions catalyzed by chloroperoxidase.
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to further understand the differences and similarities
between peroxidases and P450s as well as to probe the
structural basis for the wide range of activities exhibited
by CPO. We have crystallized and solved the structure of
CPO isozyme A in two space groups. The crystal struc-
ture shows many interesting features, some previously
predicted and some hitherto unknown.
Results and discussion
Overall structure
The structure has been refined in two space groups,
P21 2121 and C2221, at 1.9 A and 2.1 A respectively
(Table 1). The root mean square deviation (rmsd)
between the two models is 0.32 A for backbone atoms
and 0.4 A for all protein atoms. The deviation of Co
atoms exceeds 1 A for only four residues at the N termi-
nus and two other residues on a surface loop. More than
90% of (4,) angles fall within the most favorable regions
of Ramachandran plots [11]. Unless otherwise stated, the
model described in this paper is the one that was refined
in space group P212121 because this crystal form
diffracted to higher resolution and had better defined
electron density for the carbohydrate structure.
Table 1. Model refinement statistics.
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Relative to the cDNA sequence [12], the crystal struc-
ture is missing 52 residues at the C terminus. The possi-
bility that the C terminus is disordered can be ruled out
because the electron density is well defined in both space
groups and the models exhibit very low temperature
(B) factors. Moreover, there is insufficient room to
accommodate the extra 52 residues in either crystal from,
and the amino acid analysis of the protein used for
crystallization correlates with the crystal structure. The
only other possibility is that the protein undergoes a
maturation cleavage event resulting in a 299-residue
catalytically active peptide and a 52-residue C-terminal
fragment (LP Hager, personal communication). The
original DNA sequence indicates that the complete CPO
gene encodes a protein of 373 amino acid residues [12].
This 373-residue polypeptide chain is processed to a
mature, secreted CPO enzyme containing 299 amino
acid residues by two proteolytic cleavages: one removes a
20 amino acid signal peptide from the N terminus and
the other removes a 52 amino acid peptide from the
C terminus. CPO undergoes at least two other post-
translational modifications. One of these is glycosylation
(discussed later) and the second is cyclization of the
N-terminal glutamic acid [13]. CPO is synthesized as a
proenzyme with the proteolytic clip between Gln(-1)
and Glul. However, the crystal structure shows that
residue -1 is still present as the cyclized pyroglutamic acid
(designated residue number 0 to allow the previous
numbering scheme to be retained).
The CPO structure was compared with 420 protein
structures in the Protein Data Bank using a three-dimen-
sional alignment algorithm (DALI [14]). A 30% sequence
identity cutoff was applied. The comparison reveals that
the CPO polypeptide folds into a novel tertiary structure
(Fig. 2). The helical content (-50%) is similar to that
found in other peroxidases and P450s, but the overall
topology lacks any resemblance to these other heme
enzymes. Nevertheless, there are important structural
similarities near the active site. As with other heme per-
oxidases and other proteins, CPO folds into N-terminal
and C-terminal domains with the heme sandwiched
between the two domains. The fold comprises eight
ot-helical segments (A-H), three short 3 10 helices (C', D'
and G') and a short antiparallel pair (Table 2). Like
other heme enzymes, CPO has a proximal helix (helix A)
on the side of the heme containing the protein axial
heme ligand, and a distal helix (helix F) that provides cat-
alytic groups required for peroxide activation. Whereas in
CPO the proximal helix A is approximately perpendicu-
lar to the heme plane, in both the peroxidases and P450s
it is parallel to the heme plane. As anticipated from
chemical modification studies [15], Cys29 provides the
thiolate heme ligand. The axial ligand residue is in the
N-terminal domain in CPO, whereas in other heme
enzymes it resides in the C-terminal domain. The only
other two cysteines, Cys79 and Cys87, form a disulfide
bond (Fig. 2). Three prolines (Pro9, Pro230 and Pro292)
adopt a cis conformation and one of these (Pro9) is in a
classical cis-proline turn [16].
Proximal heme ligand
The polypeptide from residues 26-37 encompasses the
cysteine ligand (Cys29) and provides a rigid scaffolding
for the iron-sulfur interaction. The side chain of Asn33
forms a pair of hydrogen bonds with the backbone atoms
of Ala27, while the side chains of Arg26 and Asp37 form
hydrogen bonds to each other (Fig. 3). This conforma-
tion differs significantly from that present in P450cam in
which the cysteine-ligand region is held together by an
antiparallel 13-pair hydrogen-bonding pattern. As with
the P450 cysteine ligand, the Cys29 ligand in CPO is sit-
uated at the N terminus of the proximal helix. However,
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Fig. 2. (a) Stereo representation of the
CPO molecule. oa helices are shown in
red and are labeled with upper-case
letters from A-H and 3 10 helices are
labeled with primed letters. The 1 pair
is shown as blue arrows. The cation is
indicated as a pink sphere near a heme
propionate. The N and C termini are
only 5.6 A apart and are bridged by a
solvent molecule (not shown). (b) Stereo
diagram of the Ca trace of CPO with
every tenth Ca position labeled. (Figure
made with SETOR [52].)
in CPO the proximal helix is located in the N-terminal
half of the protein while in P450 the cysteine ligand
(Cys357 in P450cam) is located near the C terminus.
Moreover, as noted above, the proximal helix in CPO
is perpendicular to the heme while in P450cam the
proximal helix is parallel (Fig. 4a).
Even though the proximal helices are oriented very
differently in CPO and P450, the conformation of the
polypeptide backbone for a three-residue stretch
surrounding the cysteine ligand is the same. The
Pro-Cys-Pro backbone conformation in CPO superim-
poses on the X-Cys-X backbone of the various known
P450 structures [10,17-20] with an rmsd of -1 A. Of
particular interest is the very similar hydrogen-bonding
arrangement between the cysteine sulfur atom and the
neighboring peptide amide groups (Fig. 4a). In both
CPO and P450cam, the cysteine ligand is at the begin-
ning of the proximal helix. The N-terminal ends of
helices often have amino acid side chains which serve to
accept hydrogen bonds from peptide amide groups
which, at the beginning of helices, have no peptide
carbonyl oxygen hydrogen-bond partner [21]. The
cysteine ligand in both CPO and P450cam serves this
purpose. In CPO, the Cys29 sulfur is approximately
3.6 A from the peptide amide groups of residues 31 and
32 while in P450cam, the sulfur of Cys357 is approxi-
mately 3.6 A and 3.3 A from the peptide amide groups of
residues 358 and 359, respectively. This unusual
amide-sulfur hydrogen bond may be of general signifi-
cance in iron proteins that use cysteine as ligands [22].
For example, all four cysteine residues that serve as iron
ligands in nitrogenase [23] form similar interactions at the
N termini of helices. A superimposition of the
Pro-Cys-Pro backbone in CPO with the four similar
regions in nitrogenase gives rmsd values between 0. 66 A
and 0.87 A (Fig. 4b). These similarities indicate that
Table 2. Secondary structures.
Helix Beginning Ending No. of
residues
A C29 O...N N33 A34 O...N H38 10
B S49 O...N L54 P57 O...N M61 13
C A64 O...N 168 E80 0...N G84 21
C' N95 O...N A98 4
D D131 O...N F135 Q136 O...N D140 10
D' D140 O...N A143 4
E D149 O...N M153 S164 O...N D168 20
F K176 O...N Q180 1187 O...N V191 16
G R206 O...N W210 W213 O...N E217 10
G' Y221 O...N G244 4
H E233 O...N V237 A243 O...N A247 15
Beginnings and endings of helices are defined by the first and
last 1--4 hydrogen bonds, respectively. Primes indicate 310
helices; 3 pair: 45-48, 91-94.
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Fig. 3. Stereo diagram showing the
hydrogen-bonding interactions that help
to stabilize the cysteine-ligand loop.
Key residues participating in hydrogen
bonds are labeled. Dashed lines denote
hydrogen bonds. (Figure made with
SETOR [521.)
Fig. 4. (a) Conformation of the poly-
peptide near the cysteine ligand in
CPO and P450cam. The dashed lines
indicate helical hydrogen bonds while
the thin solid lines indicate the hydro-
gen bonds between the cysteine sulfur
and peptide amide groups. Note that in
CPO the helix is perpendicular to the
heme, whereas in P450 the helix is
parallel to the heme. (Figure made with
MOLSCRIPT [53].) (b) Stereoview show-
ing the superimposition of the CPO
cysteine-ligand region on three iron-lig-
ating regions in nitrogenase. The CPO
helix is shown as a thick line and the
four helices of nitrogenase are shown as
thin lines. The peptide amide-sulfur
hydrogen bonds found in CPO and
P450 also are present in the nitrogenase
helices. (Figure made with SETOR [521.)
peptide amide-sulfur ligand hydrogen bonds may be a
characteristic and important feature for metalloproteins
that utilize cysteine residues to coordinate iron.
Heme environment
As with many heme proteins, the heme in CPO deviates
from planarity and is bowl shaped (Table 3). The iron is
displaced 0.14 A below the mean plane of the porphyrin
towards the cysteine ligand compared with 0.4 A for
high-spin P450cam. The iron-sulfur bond distance is
2.3 A in both CPO crystal forms which is the same as
the distance estimated by extended X-ray absorption fine
structure analysis [24]. The opposite (distal) side of the
heme is occupied by a solvent molecule which is
positioned 3.4 A from the iron atom and too far away to
form a strong axial ligand. This is consistent with the
high-spin spectroscopic properties of ferric CPO [25].
As with other heme proteins, the heme is held in place
by both hydrophobic and hydrogen-bonding interactions.
The environment around the heme propionates is more
similar to peroxidases than P450s. In P450cam the propi-
onate groups are surrounded by charged side chains. The
propionates in CPO, however, interact primarily with
backbone atoms. The loop between Glu104 and SerllO
provides the primary set of interactions (Fig. 5).
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The most notable and unexpected feature involving
heme interactions is a cation coordinated by one of the
heme propionates. At the early stage of modeling water
molecules, very strong difference density was observed
near a heme propionate (Fig. 5). This was subsequently
attributed to a cation when the difference density was still
over 20 times above background with water included at
this site, and because the site is surrounded by protein
oxygen atoms and solvent molecules. Electron paramag-
netic resonance studies indicated the presence of a Mn2 +
ion [26] and this was later confirmed by X-ray fluores-
cence spectroscopy [1]. Hence, this has been tentatively
modeled as a Mn2 +-binding site. In addition to the heme
propionate, the cation is coordinated by five other pro-
tein and water ligands in an octahedral geometry (Fig. 5).
The location and coordination geometry of the cation is
remarkably similar to that of the Mn2+-binding site in the
crystal structure of manganese peroxidase [27]. In man-
ganese peroxidase, the Mn2+ ion also coordinates with a
heme propionate, but in this case the Mn 2 + ion is a sub-
strate [28]. While the exact role of Mn2 + ion in CPO has
yet to be established, studies have shown that the activity
of the enzyme is not altered by the presence or absence
of Mn 2+ (LP Hager, personal communication).
Fig. 5. Stereoview of the cation-binding
site. The map is an F-F c omit difference
electron-density map contoured at 12
times above background level. Ligand
interactions with the cation are indi-
cated as dashed lines. (Ligands for Mn2+
and distances: heme propionate 02A,
2.33 A; side-chain carboxyl Oe1-
Glu104, 2.10 A; carbonyl O-HislO05,
2.06 A; side-chain Oy-Ser108, 2.28 A;
water802, 2.33 A; water803, 2.40 A.)
Also shown are the hydrogen-bond
interactions of the heme and olvoeo-
tide. (Figure made with SETOR [521.)
Distal heme pocket
Although CPO has a thiolate heme ligation similar to
that in P450s, the opposite or distal face of the heme is
expected to resemble the polar peroxidase active site
rather than the more non-polar P450 active site [10].
Crystal structures of cytochrome c peroxidase (CcP) and
catalase have revealed that both possess a distal histidine
[9,29]: His52 in CcP is perpendicular to the heme plane
and His74 in catalase is parallel. In both enzymes, the
distal histidine works in concert with another polar
residue (arginine in peroxidases and asparagine in
catalase) in an acid-base catalytic mechanism required to
cleave the peroxide 0-0 bond in the formation of
compound I [30]. Various equilibrium binding studies of
exogenous ligands and halides binding to the CPO heme
iron have revealed the presence of a titratable residue that
affects the binding. This residue has generally been
considered to be a distal histidine [6-8].
The crystal structure reveals a somewhat different picture.
The heme pocket in CPO is polar as predicted, but the
acid-base catalytic group is not histidine. Instead, the side
chain of Glu183 extends from the distal helix F and is
positioned directly adjacent to the peroxide-binding site
(Fig. 6). Histidine, however, is involved indirectly.
Hisl05 hydrogen bonds with Glu183 and the carbonyl
oxygen of Asp106. This arrangement is quite different
from that found in the heme peroxidases where both the
catalytic histidine and arginine extend from the distal
helix and can interact with the iron-linked peroxide.
Glu183 in CPO is the only polar or charged group close
enough to the peroxide-binding site to serve a direct
catalytic role. The most probable role of HislO5 is to
correctly orient Glu183 and, possibly, provide
charge-charge interactions. It should be noted that
HislO5 is only 3.5 A above one of the propionate
carboxylate groups (Fig. 6), thus increasing the pKa of
the histidine side chain. Also of note is the fact that the
propionate with which Hisl05 interacts is the same
propionate that is a ligand for the cation. This intricate
Table 3. Heme geometry.
Parameter Distance (A) Angle (°)
Fe to Cys29 Sy 2.30
Fe to pyrrole N (average) 2.04
Fe to pyrrole N plane 0.14
Cys29 Sy to pyrrole N plane 2.44
Fe to porphyrin plane 0.36
Pyrrole N plane to porphyrin plane 0.94
Pyrrole A plane to porphyrin plane 5.78
Pyrrole B plane to porphyrin plane 5.73
Pyrrole C plane to porphyrin plane 10.91
Pyrrole D plane to porphyrin plane 7.99
Cys29 Sy-Fe bond vector to pyrrole N normal 177.37
CO-Sy -Fe 110.54
Cys29 side-chain torsion angle 174.00
I
O ' ' ' - - . .- - , . .
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set of electrostatic and hydrogen-bonding interactions
involving side chains, the heme, and a cation may be
important for catalysis and could imply a role for the
cation other than a simply structural one.
Glu183 at the active site can help to explain some of the
solution and pH properties of CPO. While ligands bind
to the iron as the anion, CPO accepts weakly acidic
ligands such as HCN (pKa>3 ) into the active site in the
neutral protonated form, whereas strong acids like HNO3
(pKa<O) bind preferentially at low pH as the anion [31].
The presence of the negatively charged carboxylate on
Glu183 would be expected to repel entry of the anionic
form of weak acids owing to unfavorable electrostatic
interactions. Strong acids enter the active site in their
anionic form only at low pH when Glu183 is protonated.
The exact catalytic role of Glu183 is probably similar to
that of the distal histidine in peroxidases. The carboxylate
accepts a proton from the incoming peroxide and donates
a proton to the leaving hydroxyl group:
Fe3+ GuCO2-+H 20 2-- Fe3+-O-OH GluCO2H->
Fe3 +-O GluCO2-+H 2 0
Fig. 6. Stereoview of the CPO active site.
Hydrogen bonds involving the distal side
water molecule, Glu183 (the proposed
acid-base catalyst) and Hisl05 are
shown as dashed lines. The histidine is
only 3.5 A from the heme propionate
that binds a cation. The proposed sub-
strate-binding pocket is bracketed by
Phel03 and Phe186. (Figure made with
SETOR [52].)
The Fe3 +-O species then oxidizes the porphyrin and
iron to give compound I. In CcP, the crystal structure of
compound I shows that the active-site arginine residue
moves in to interact with and probably stabilize the oxy-
gen of the Fe4 +=O center [32]. The electrostatic envi-
ronment in CPO clearly must be different if Glu183,
either as the anionic carboxylate or protonated carboxyl
group, also interacts directly with the Fe4 +=O oxygen
atom. In either case, the energetics should be quite dif-
ferent from those in other peroxidases, such as horse-
radish peroxidase, that form considerably more stable
compound I porphyrin T-cation radical and Fe4 +=O
centers than in CPO [33].
Substrate-binding pocket
In heme peroxidases the heme edge is available for sub-
strate interactions but direct access to the Fe4 +=O center
is restricted. The opposite is true in P450s, in which the
heme edge is not accessible but a substrate pocket exists
directly adjacent to the Fe4 +=O center. The crystal
structures of two P450-substrate complexes [10,20] with
very different specificities clearly show that the substrate
is surrounded by protein groups required for holding the
Fig. 7. Stereoview of the van der Waals
surface of the substrate-binding region.
Colour coding is as follows: blue,
charged/polar side chains; green, back-
bone atoms; yellow, hydrophobic side
chains. The red region at the bottom of
the proposed substrate-binding site is
the catalytic Glu183 which is situated
just above the heme. (Figure made with
GRASP [54].)
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substrate in place for stereospecific hydroxylation.
Because the heme edge is not connected to the molecu-
lar surface via a channel as it is in other peroxidases, CPO
more closely resembles P450 in this respect. However,
there is a small opening above the heme which could
allow access to the Fe4 +=O center in compound I
(Fig. 7). This channel, which connects the surface to the
heme distal side, is formed by the C, F and H helices and
loops 263-269 and 101-110. The channel is mostly
hydrophobic near the heme and wider and more polar at
the top. A mannose carbohydrate bound to Thr238 is
located at the opening of the channel, but would not
prevent substrate entry. Glu69 and Glu266 are also
located near the entrance of the channel but these
residues appear to be quite flexible, as indicated by their
high temperature factors.
hydrophobic patch that will only partially bury an
aromatic substrate the size of dimethylaniline. This may
account for the rather broad range of specificities exhib-
ited by CPO in various P450-like reactions. By contrast,
in P450 numerous specific protein-substrate interactions,
sequestered from bulk solvent, rigidly orient the substrate
for stereospecific hydroxylation.
The side chains of Phel03, Val182 and Phel86 are situ-
ated at the bottom of this opening, and are available for
interactions with organic substrates. One such substrate
is dimethylaniline which can undergo a CPO-catalyzed
oxidative demethylation [34]. Docking of dimethyl-
aniline into the CPO access channel results in hydro-
phobic contacts with the side chains of Phe103, Leu70,
Phe186, Vall182 and Ala267. However, much of the sub-
strate remains exposed to solvent and there is no indica-
tion, such as a disordered loop nearby, of an open/close
motion that might result in a more buried substrate. Such
a mechanism has been proposed to occur in P450s on the
basis of energy minimization and molecular dynamics
simulations [19,35].
Nevertheless, there are indications that the bottom of the
pocket can adjust to substrate binding. PhelO3, one of
the residues at the bottom of the channel expected to
contact substrates, appears to be flexible. This flexibility
is intimated by a difference in the heme-phenyl ring dis-
tances in the two crystal structures. The phenyl ring is
closer to the heme in the P2 12 121 form by 0.2 A relative
to the C2221 form. Furthermore, the temperature factors
are higher for this residue compared with the other
residues in the region. A difference Fourier map calcu-
lated with one of the heavy-metal derivative data sets in
the C2221 form showed strong positive difference density
above the heme iron on the distal side. This density is
consistent with a diatomic molecule bound to the heme
iron, probably a contaminant in the heavy-atom reagent.
The model refined with this heavy-metal derivative data
set in C222 1 form showed a larger deviation in the
PhelO03-heme distance (0.4 A). The flexibility is also
manifested in the slight rearrangement of solvent mol-
ecules in the access channel. The residual electron den-
sity in the channel close to PhelO03, which was modeled
as water molecules, is stronger and continuous, extending
to the phenyl ring in the C222 1 form. The presence of
310 mM NaCl in the crystallization medium used to
grow crystals of this form might be responsible for the
differences in heme-phenyl ring distances as crystal con-
tacts are not involved in this region in either space group.
This opening appears to provide a somewhat flexible
Fig. 8. (a) F-F c omit electron-density maps contoured at 2.5o-
for the 14 carbohydrate attachment sites found in the P2,1212
crystal form. (b) The structure of the most extensively branched
site which is attached to Asn93.
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Fig. 9. Stereoview showing the back-
bone of CPO and the location of all
observed carbohydrate units. The O-gly-
cosylation sites are shown in red and
the N-glycosylation sites in blue. (Figure
made with SETOR [52].)
CPO still exhibits some selectivity with respect to sub-
strate size and stereochemistry in the oxidation of aro-
matic molecules. Substrates with bulky substituents are
not oxidized while, for example, only the L isomer of
N-acetyl tyrosine is oxidized [36]. The size-dependence
is relatively easy to rationalize as the hydrophobic patch is
small and cannot accommodate very large aromatic mol-
ecules. The stereoselectivity is a more intriguing prob-
lem. The modeling we have carried out so far indicates
that simple steric considerations govern the stereoselec-
tivity of CPO. We hope to be able to test these hypothe-
ses by diffusing selected substrates into the CPO crystals.
A discussion of CPO substrates would not be complete
without considering where and if halides (specifically
chloride) bind. The C222 1 crystal form grows in the
presence of 310 mM NaC1l. If C1- bound tightly and
specifically to some site on the enzyme, we might antici-
pate that one of the solvent molecules modeled as water
would be situated in extra electron density corresponding
to the much larger (18 electrons) C1- ion. We found no
such peak although the C222 1 form grown in high NaC1l
buffers does contain some extraneous but not very well
defined electron density near the proposed substrate-
binding site. Further predictions from the crystal struc-
ture on where and how an active chlorinating
intermediate is formed are complicated by the complex
and uncertain chemistry involved. For example, the
precise identification of the chlorinating species and
which enzyme intermediate is involved is an unsolved
problem with CPO [3]. It is unclear whether chlorina-
tion takes place while substrates are bound to CPO or
whether the chlorination is an enzyme-free reaction
involving HOC1 as the active agent, although free HOC1
is favored [3]. There are also suggestions that it is the
oxy-complex of CPO and not compound I which is the
active intermediate [3]. Radical mechanisms have been
proposed where both the organic substrate and C1- are
oxidized in separate steps with the radical ultimately
chlorinated by C12 [3]. The structure does not allow
us to choose between these various mechanisms but at
the very least, the resting enzyme appears not to have a
specific high-affinity site for Cl-.
Glycosylation
The two major isozymes of CPO, A and B, have the
same amino acid composition but different carbohydrate
composition. Form A, used in these studies, is more
heavily glycosylated and carbohydrate accounts for about
19% of the total molecular weight [13]. The crystal struc-
ture shows 14 glycosylation sites, with a total of 21 sugar
molecules in the P2 121 21 form (Figs 8,9; Table 4),
whereas the C222 1 form has only 13 carbohydrate
groups. Because the content, but not the sequence, of
carbohydrate groups is known in CPO, the following dis-
cussion on carbohydrate structure is based on other simi-
lar glycoproteins [37] and the size and shape of electron
density envelopes in the higher-resolution P21 2121 form.
































Abbreviations: GlcNAc, N-acetylglucosamine; Man, mannose;
Xyl, Xylose; Arb, Arabinose.
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The three N-linked glycosyl chains are more complex
than the eleven O-linked chains, with a minimum of two
N-acetylglucosamine (GlcNAc) molecules in 1--4
linkages (Fig. 8). At the first site, Asnl2, the electron
density is very clear for one GlcNAc molecule. Although
the density extends beyond the first GlcNAc, a second
molecule could not be modeled as the density was too
weak - probably because the molecule is disordered.
The second site, at Asn93, has two molecules each of
GlcNAc, mannose and xylose. The second GlcNAc is
[31--4 linked to a mannose where the chain branches
with otl-6 and ol--3 linked xyloses and one of these is
aol-3 linked to a mannose (Fig. 8). A similar pattern of
branching is observed in the crystal structure of gluco-
amylase at pH 4 [37], which is classified as a high-man-
nose type [38]. The third site, at Asn216, has only two
clearly defined GlcNAc molecules. The amino acid
sequence at all the three sites conforms to the pattern
Asn-X-Ser/Thr.
The C-terminal domain is rich in serine and threonine
residues. All of the observed O-glycosylation sites are
located in this domain. With the exception of Thr275,
which is glycosylated with an 1 ---2 linked
mannose-arabinose dimer, only a single mannose unit
was visible at each of the O-linked glycosyl positions
(Figs 8,9). Weak residual electron density indicates a sec-
ond sugar at sites Thr283 and Thr293 but these sugars
were not included in the model.
Biological implications
Chloroperoxidase (CPO) is the most diverse of the
known heme enzymes owing to its ability to cat-
alyze peroxidase, catalase and P450-like reactions.
It has long been anticipated that CPO would con-
tain a pocket on the proximal side of the heme
similar to that found in P450s and a distal pocket
resembling the peroxide-binding site of peroxi-
dases. The crystal structure is consistent with
these expectations, although the active-site
acid-base catalytic group is identified as a gluta-
mate and not a histidine as expected. The very
close similarity between CPO, P450 and other sul-
fur-iron proteins in the hydrogen-bonding pattern
involving the cysteine heme ligand and nearby
peptide amide groups indicates an important role
for these hydrogen bonds in sulfur-iron ligation.
The sulfur not only hydrogen bonds with peptide
amide groups but is also situated at the N-termi-
nal or positive dipole end of an ox helix. Hence,
the cysteine sulfur atom is surrounded by, and
very likely stabilized by, a positive electrostatic
environment. This is in direct contrast to the case
of the proximal histidine ligand in peroxidases
where the ligand is situated at the C terminus of
an c( helix and hydrogen bonds with an aspartate.
It appears that in these iron-sulfur proteins, the
goal is to diminish the negative charge on the sul-
fur ligand, while in peroxidases the goal is to
increase the negative charge on the ligand. In per-
oxidases it has been argued that the reason for this
arrangement is to decrease the redox potential of
the heme iron. Using the same argument for sul-
fur-iron proteins, the local electropositive envi-
ronment may be necessary to increase the heme
iron redox potential.
Another structural feature of heme enzymes that
governs biological activity is the accessibility of
the active site. It is generally believed that P450s
and peroxidases utilize a similar Fe4 +=O0 oxidizing
center and that access to this center helps to
determine the type of activity that is exhibited.
Heme peroxidases have restricted access to the
Fe4 +=O center; hence they accept electrons from
reducing substrates via the heme edge. This leads
to the production of substrate radicals. In con-
trast, P450s have substrate pockets directly adja-
cent to the Fe4 +=O center allowing for
stereoselective hydroxylation of substrates. CPO
more closely resembles P450s in that a small
opening above the heme allows access to the
Fe4 +=O center. Nevertheless, CPO also exhibits
peroxide-degrading activities typical of peroxi-
dases and catalase. Part of the P450-like activity
may be controlled by the cysteine ligand as well as
accessibility to the Fe4 +=O center. The peroxi-
dase-like activity is determined, in part, by the
relative stability of CPO compound I compared
with P450: the peroxide-binding site is more polar
in CPO. The additional stability of CPO com-
pound I allows substrates that cannot approach
close enough for direct oxidation by the Fe4+=O
center the time to bind and transfer an electron.
Much of this is speculative, but the availability of
several new P450 and peroxidase structures, and
now the CPO structure, should help to provide a
much better correlation between known biological
activities and structure.
Materials and methods
Protein purification and crystallization
The enzyme was purified from Caldariomyces fiimago as
described by Blanke et al. [39]. Details of crystallization and
data collection have been reported [40]. Briefly, two
orthorhombic crystal forms, one primitive and the other cen-
tric, have been grown using polyethylene glycol (PEG) 6000 as
the precipitant in the presence of 10 mM potassium phosphate
buffer at pH 6.0 by the hanging drop vapor diffusion method
at room temperature (20 0 C). The primitive form grows at
higher concentrations of PEG (30% w/v) than the centric form
(20% PEG), but the latter requires the presence of 310 mM
NaCl. Both crystal forms, each with a single molecule in the
asymmetric unit, were used in the structure determination:
C222 1 (a=58.43 A, b=152.76 A, c=102.29 A, Z=8) and
P2,21 21 (a=58.77A, b=71.36 A, c=91.73 A, Z=4). The C2221
form, grown using seeding procedures, diffracts to a resolution
of about 2.1 A, while the spontaneously grown P212121 form
diffracts to 1.9 A.
1376 Structure 1995, Vol 3 No 12
Data collection
The details of data collection for native crystals of both space
groups and heavy-atom derivatives of the C222 1 space group
have been reported [40]. Heavy-atom derivatives have been
prepared since for the P212121 form and the data have been
collected on a Siemens area detector using a rotating anode
X-ray source equipped with focussing optics. The data were
processed and scaled using XENGEN [41]. Native anomalous
data were collected by swinging the crystal about the b* axis
alternately 1800 apart at 600 intervals until the complete 3600
was swept and scaled without merging Bijvoet pairs. Derivative
anomalous data were collected without optimizing for record-
ing Bijvoet pairs as described above, but simply scaling the data
without merging the Bijvoet pairs. Native and derivative data
sets were collected from single crystals at ambient temperatures.
Typically, the derivatives were prepared by soaking crystals in
20 pl artificial mother liquor (30% PEG 6000, with no buffer)
containing -1-4 mM heavy-metal compound for 1-2 days.
The data collection details are provided in Table 5.
Structure solution
The heme iron position was located using the native anom-
alous difference Patterson map and the heavy-atom positions
by isomorphous difference Patterson maps and were confirmed
by the cross-difference Fourier maps. Multiple isomorphous
replacement (MIR) phases were calculated to 2.7 A in both
space groups. The combined figures of merit for the C2221 and
P212121 forms were 0.68 and 0.69, respectively. All the calcu-
lations up to this point were performed using PHASES [42].
The phasing statistics are provided in Table 5.
Initially, a spherical mask was constructed around the asym-
metric unit from the solvent-flattened map of the C222 1 form
using MAMA [43] and was later edited to cover the asymmet-
ric unit as completely as possible using bones (or bone images)
as a guide in O [44]. The non-crystallographic relation
between the two space groups was established by the least-
squares superimposition of five common heavy-atom sites and
refined using the electron density correlation of the asymmetric
units in the two space groups using MAVE [43]. The MIR
maps were averaged and solvent flattened followed by his-
togram matching, and the phases were extended to 2.1 A using
MAGICSQUASH [45] in the CCP4 suite of programs [46].
The averaged maps were of excellent quality and clearly
showed the backbone density and many bulky side chains. The
polypeptide from residue 5-254 and residue 281-298 was built
and the remaining portions of the backbone density were fitted
with a polyserine model using FRODO [47].
Refinement
The model was refined at this stage by simulated annealing
using X-PLOR [48] to an R-factor of about 0.31 in both
space groups. The calculated phases from refined partial mod-
els were combined with the MIR phases using SIGMAA [49]
in CCP4 and a new round of averaging, solvent flattening,
histogram matching and phase extension was performed using
a new mask obtained from the model. The maps calculated
from the new phase sets showed considerable improvement in
the previously poorly defined regions and the remaining por-
tions of the chain could be traced with ease. This exercise was
repeated until the complete polypeptide could be traced and
all the side chains had been fitted. Once the complete
polypeptide was built, no more map averaging between the
two space groups was necessary. The models were further
improved using omit maps calculated by excluding the regions
under examination from refinement and phase calculations,
and rebuilding those regions. During this stage of model
building, electron density for many carbohydrates sites became
clear and these sites were included in the model in a stepwise
manner once the density could be interpreted beyond doubt.
Ordered solvent molecules were included at this stage in sev-
eral steps based on the following three criteria: first, there
should be 3 Fo-F c density and lo 2Fo-F c density; second,
the solvent peak should be within hydrogen-bonding distance
of protein atoms or other solvent atoms, and third, the B-fac-
tors should be less than 60 A2. At the final stages, conventional
positional and individual B-factor refinements were carried
out using X-PLOR. The quality of the models was assessed
using PROCHECK [50].
Atomic coordinates have been submitted to the Brookhaven
Protein Data Bank.
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Table 5. Data collection and phase refinement statistics.
Data set Resolution (A) Reflections Complete (%)* Rsymt Riso* No. of Rcuiis§ Phasing power#
measured unique sites (2.7 A)
Native 1.90 152 222 29 366 94 (75) 0.082
GdCI 3 2.20 98201 19976 97 (86) 0.070 0.119 1 0.674 1.23
K2PtCI4 2.40 86687 15414 99 (94) 0.106 0.147 3 0.638 1.21
HMPS** 2.50 67701 13397 96 (76) 0.105 0.115 3 0.650 0.89
GdCI 3 anomalous 2.20 100333 36571 96 (79) 0.054 1 1.22
Native anomalous 2.67 92484 14455 69 (48) 0.039 1 1.68
*The overall completeness is given, with the completeness in the highest resolution shell shown in parentheses.
tRsym,=hi I <I(h)>-I(h)i /,h. i (h)i, where I(h) is the intensity of reflection h, Eh is the sum over all reflections and Ei is the sum over
all i measurements of reflection h. Riso=,hlFpH-Fpl/.FhFp, where FPH and Fp are the native and derivative structure-factor
amplitudes, respectively. §RCullis==h I I FpHFp -FH I/'h I FpH±Fp , where FH is the calculated structure-factor amplitude of the heavy-
atom structure. #Phasing power=FH/E, where E is the estimated lack of closure error. **HMPS, hydroxymercuricphenylsulfonic acid.
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